Evidence map›Paper›PMID 30762108›Full record

ArticleArchives of gynecology and obstetrics2019

Sentinel lymph node mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the method.

M Bedyńska, G Szewczyk, T Klepacka, K Sachadel, T Maciejewski, D Szukiewicz, A Fijałkowska

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Archives of gynecology and obstetrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07380698 (The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07380698 recruitingnot on this mapstarted 2025, after this paper: background citation

The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer

Typeobservational_patient_registrySponsorCukurova UniversityRan2025 to 2026Enrolled30ConditionsEndometrial Cancer, Vulvar Cancers, Cervical Cancer, Indocyanine Green (ICG)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

M BedyńskaDepartment of Obstetrics and Gynecology, Institute of Mother and Child, Kasprzaka 17a St., 01-211, Warsaw, Poland. mariabedynska@wp.pl.ORCID 0000-0002-3075-8977
G SzewczykDepartment of Obstetrics and Gynecology, Institute of Mother and Child, Kasprzaka 17a St., 01-211, Warsaw, Poland.
T KlepackaDepartment of Pathology, Institute of Mother and Child, Warsaw, Poland.
K SachadelDepartment of Obstetrics and Gynecology, Institute of Mother and Child, Kasprzaka 17a St., 01-211, Warsaw, Poland.
T MaciejewskiDepartment of Obstetrics and Gynecology, Institute of Mother and Child, Kasprzaka 17a St., 01-211, Warsaw, Poland.
D SzukiewiczDepartment of General and Experimental Pathology, Medical University of Warsaw, Warsaw, Poland.
A FijałkowskaDepartment of Cardiology, Institute of Mother and Child, Warsaw, Poland.
Medical University of Warsaw · PLMother and Child Foundation · GBPolish Mother’s Memorial Hospital Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo establish the surgical, demographic and histopathological factors associated with inaccurate sentinel lymph nodes (SLNs) identification using indocyanine green (ICG) and near-infrared (NIR) fluorescence imaging in uterine and cervical neoplasms during both open and laparoscopic surgery.

methodsWe reviewed patients with atypical endometrial hyperplasia (AEH), clinical stage I and II cervical cancer or uterine malignancies who underwent primary surgery with SLN mapping between September 2015 and January 2018. An analysis of patients' demographics, tumor factors and surgical approach was conducted. Bilateral and overall detection rates were calculated and univariate analysis was performed to estimate factors associated with failed SLN mapping.

resultsA total of 32 patients with uterine and cervical neoplasms were included in the study. The overall detection rate of the SLN was 84% and bilateral detection rate was 75%. There were no statistically relevant differences in overall and bilateral SLN detection rates by BMI, surgical approach or age. Regarding endometrial cancer, there were no differences in SLN detection rates when comparing tumor grade, histology nor myometrial invasion. For SLN detection failure, only the presence of metastatic lymph nodes and lack of surgical experience significantly increased the disability to detect SLNs (p = 0.03, p = 0.04, respectively).

conclusionsSLN mapping technique using NIR fluorescence imaging with ICG appears to be accurate method in most of the patients with cervical or endometrial carcinoma, regardless of demographic characteristics, tumor-related features and surgical approach. Surgeons' expertise in that field allows obtaining excellent detection rates.

Indexed as

AdultAgedAged, 80 and overFemaleHumansIndocyanine GreenLymph NodesMiddle AgedRetrospective StudiesSentinel Lymph NodeSentinel Lymph Node BiopsyUterine Cervical NeoplasmsUterine NeoplasmsIndocyanine GreenCervical cancerEndometrial cancerIndocyanine greenSentinel lymph node

Identifiers

PMID30762108
PMCPMC6475506
OpenAlexW2911508750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.